首页> 外文会议>IEEE Engineering in Medicine and Biology Society., Conference. >Impact of haemodialysis on insulin sensitivity of acute renal failure (ARF) patients with sepsis in critical care
【24h】

Impact of haemodialysis on insulin sensitivity of acute renal failure (ARF) patients with sepsis in critical care

机译:血液透析对急性肾功能衰竭(ARF)脓毒症患者急性护理患者的影响

获取原文

摘要

Critically ill patients often develop renal failure in addition to their primary diagnosis. However, the effect and impact of haemodialysis (HD) on insulin sensitivity n critically ill patients remains unclear. Specifically, this study investigates insulin sensitivity of acute renal failure (ARF) patients with sepsis who underwent HD and glycaemic control. Model-based insulin sensitivity (S_I) profiles were identified for 20 critically ill ARF patients on Specialized Relative Insulin Nutrition Titration (SPRINT) glycaemic control during intervals onto HD (OFF/ON), and after HD (ON/OFF). Patients exhibited a median -18% (IQR -36% to -5% p<0.05) reduction in measured S_I after the OFF/ON dialysis transition, and a median 9% (IQR -5% to 37%, p<0.05) rise after the ON/OFF transition. Almost 80% of patients exhibited decreased S_I at the OFF/ON interval, and 60% exhibited increased S_I at the ON/OFF transition. Results indicate that HD commencement has significant effect on insulin pharmacokinetics at a cohort and per-patient level. These results provide the data to design conclusive studies of HD effects on S_I, and to inform glycaemic control protocol development and implementation for this specific group of critically ill patients with ARF-sepsis.
机译:危重病患者往往会发育肾功能衰竭,除了他们的初步诊断。然而,血液透析(HD)对胰岛素敏感性患者的效果和影响尚不清楚患者仍然尚不清楚。具体而言,本研究研究了急性肾功能衰竭(ARF)患者患有HD和血糖控制的败血症患者的胰岛素敏感性。基于模型的胰岛素敏感性(S_I)鉴定在间隔期间,在HD(OFF / ON)和HD(ON / OFF)之后,对专业相对胰岛素营养滴定(Sprint)血糖对照鉴定出20名批判性胰岛素营养滴定(Sprint)血糖控制。在透析/上的透析转变后测量S_I,测量的S_I降低了患者的中位数-18%(IQR -36%至-5%P <0.05),中位数9%(IQR -5%至37%,P <0.05)开/关过渡后崛起。近80%的患者在OFF / ON间隔内表现出降低的S_I,60%的ON / OFF过渡表现出S_I增加。结果表明,HD跃点对群组和每患者水平的胰岛素药代动力学产生显着影响。这些结果为数据提供了对S_I对HD效应的决定性研究的数据,并告知血糖控制协议的开发和实施该特定患有ARF-epsis的危重病患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号